150 related articles for article (PubMed ID: 24098713)
1. Blockade of the formation of insoluble ubiquitinated protein aggregates by EGCG3"Me in the alloxan-induced diabetic kidney.
Cai S; Zhong Y; Li Y; Huang J; Zhang J; Luo G; Liu Z
PLoS One; 2013; 8(9):e75687. PubMed ID: 24098713
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic and proteomic effects of (-)-epigallocatechin 3-O-(3-O-methyl) gallate (EGCG3"Me) treatment on ethanol-stressed Saccharomyces cerevisiae cells.
Chen Y; Cheng L; Zhang X; Cao J; Wu Z; Zheng X
Food Res Int; 2019 May; 119():67-75. PubMed ID: 30884702
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the transcriptional regulator CsbHLH62 that negatively regulates EGCG3"Me biosynthesis in Camellia sinensis.
Luo Y; Yu SS; Li J; Li Q; Wang KB; Huang JA; Liu ZH
Gene; 2019 May; 699():8-15. PubMed ID: 30851424
[TBL] [Abstract][Full Text] [Related]
4. Cloning of a caffeoyl-coenzyme A O-methyltransferase from Camellia sinensis and analysis of its catalytic activity.
Zhang Y; Lv HP; Ma CY; Guo L; Tan JF; Peng QH; Lin Z
J Zhejiang Univ Sci B; 2015 Feb; 16(2):103-12. PubMed ID: 25644465
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of tea catechins and O-methylated derivatives of (-)-epigallocatechin-3-O-gallate on mouse type IV allergy.
Suzuki M; Yoshino K; Maeda-Yamamoto M; Miyase T; Sano M
J Agric Food Chem; 2000 Nov; 48(11):5649-53. PubMed ID: 11087533
[TBL] [Abstract][Full Text] [Related]
6. Effect of green tea powder (Camellia sinensis L. cv. Benifuuki) particle size on O-methylated EGCG absorption in rats; The Kakegawa Study.
Maeda-Yamamoto M; Ema K; Tokuda Y; Monobe M; Tachibana H; Sameshima Y; Kuriyama S
Cytotechnology; 2011 Mar; 63(2):171-9. PubMed ID: 21207145
[TBL] [Abstract][Full Text] [Related]
7. Effects of Spirulina platensis on lipid peroxidation, antioxidant defenses, and tissue damage in kidney of alloxan-induced diabetic rats.
Gargouri M; Hamed H; Akrouti A; Dauvergne X; Magné C; El Feki A
Appl Physiol Nutr Metab; 2018 Apr; 43(4):345-354. PubMed ID: 29091744
[TBL] [Abstract][Full Text] [Related]
8. EGCG Inhibited Lipofuscin Formation Based on Intercepting Amyloidogenic β-Sheet-Rich Structure Conversion.
Cai S; Yang H; Zeng K; Zhang J; Zhong N; Wang Y; Ye J; Tu P; Liu Z
PLoS One; 2016; 11(3):e0152064. PubMed ID: 27030967
[TBL] [Abstract][Full Text] [Related]
9. Loganin attenuates diabetic nephropathy in C57BL/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products.
Liu K; Xu H; Lv G; Liu B; Lee MK; Lu C; Lv X; Wu Y
Life Sci; 2015 Feb; 123():78-85. PubMed ID: 25623853
[TBL] [Abstract][Full Text] [Related]
10. Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats.
Das J; Sil PC
Amino Acids; 2012 Oct; 43(4):1509-23. PubMed ID: 22302365
[TBL] [Abstract][Full Text] [Related]
11. Syringic Acid: A Potential Natural Compound for the Management of Renal Oxidative Stress and Mitochondrial Biogenesis in Diabetic Rats.
Rashedinia M; Khoshnoud MJ; Fahlyan BK; Hashemi SS; Alimohammadi M; Sabahi Z
Curr Drug Discov Technol; 2021; 18(3):405-413. PubMed ID: 32072913
[TBL] [Abstract][Full Text] [Related]
12. Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy.
Li J; Qu X; Yao J; Caruana G; Ricardo SD; Yamamoto Y; Yamamoto H; Bertram JF
Diabetes; 2010 Oct; 59(10):2612-24. PubMed ID: 20682692
[TBL] [Abstract][Full Text] [Related]
13. Rutin ameliorates metabolic acidosis and fibrosis in alloxan induced diabetic nephropathy and cardiomyopathy in experimental rats.
Ganesan D; Albert A; Paul E; Ananthapadmanabhan K; Andiappan R; Sadasivam SG
Mol Cell Biochem; 2020 Aug; 471(1-2):41-50. PubMed ID: 32529498
[TBL] [Abstract][Full Text] [Related]
14. Gliquidone Alleviates Diabetic Nephropathy by Inhibiting Notch/Snail Signaling Pathway.
Tian H; Yang J; Xie Z; Liu J
Cell Physiol Biochem; 2018; 51(5):2085-2097. PubMed ID: 30522115
[TBL] [Abstract][Full Text] [Related]
15. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice.
Ichihara A; Suzuki F; Nakagawa T; Kaneshiro Y; Takemitsu T; Sakoda M; Nabi AH; Nishiyama A; Sugaya T; Hayashi M; Inagami T
J Am Soc Nephrol; 2006 Jul; 17(7):1950-61. PubMed ID: 16738017
[TBL] [Abstract][Full Text] [Related]
16. Timosaponin B-II ameliorates diabetic nephropathy via TXNIP, mTOR, and NF-κB signaling pathways in alloxan-induced mice.
Yuan YL; Guo CR; Cui LL; Ruan SX; Zhang CF; Ji D; Yang ZL; Li F
Drug Des Devel Ther; 2015; 9():6247-58. PubMed ID: 26664046
[TBL] [Abstract][Full Text] [Related]
17. Modulation of glutathione peroxidase activity by age-dependent carbonylation in glomeruli of diabetic mice.
Wiedenmann T; Dietrich N; Fleming T; Altamura S; Deelman LE; Henning RH; Muckenthaler MU; Nawroth PP; Hammes HP; Wagner AH; Hecker M
J Diabetes Complications; 2018 Feb; 32(2):130-138. PubMed ID: 29223856
[TBL] [Abstract][Full Text] [Related]
18. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury.
Liu W; Zhang X; Liu P; Shen X; Lan T; Li W; Jiang Q; Xie X; Huang H
Eur J Pharmacol; 2010 Jul; 638(1-3):150-5. PubMed ID: 20447389
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1.
Sun W; Liu X; Zhang H; Song Y; Li T; Liu X; Liu Y; Guo L; Wang F; Yang T; Guo W; Wu J; Jin H; Wu H
Free Radic Biol Med; 2017 Jul; 108():840-857. PubMed ID: 28457936
[TBL] [Abstract][Full Text] [Related]
20. Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice.
Seok SJ; Lee ES; Kim GT; Hyun M; Lee JH; Chen S; Choi R; Kim HM; Lee EY; Chung CH
Nephrol Dial Transplant; 2013 Jul; 28(7):1700-10. PubMed ID: 23794669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
